CARBOPROST Drug Patent Profile
✉ Email this page to a colleague
When do Carboprost patents expire, and what generic alternatives are available?
Carboprost is a drug marketed by Alembic, Amneal, Ani Pharms, Caplin, Dr Reddys, Eugia Pharma, Gland, Long Grove Pharms, Micro Labs, Onesource Specialty, Sola Pharms, and Sunny. and is included in twelve NDAs.
The generic ingredient in CARBOPROST is carboprost tromethamine. There is one drug master file entry for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the carboprost tromethamine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Carboprost
A generic version of CARBOPROST was approved as carboprost tromethamine by DR REDDYS on July 2nd, 2019.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CARBOPROST?
- What are the global sales for CARBOPROST?
- What is Average Wholesale Price for CARBOPROST?
Summary for CARBOPROST
| US Patents: | 0 |
| Applicants: | 12 |
| NDAs: | 12 |
| Drug Prices: | Drug price information for CARBOPROST |
| DailyMed Link: | CARBOPROST at DailyMed |
